2
|
Kar B, Bardhan S, Ghosh P, Ganguly B, Kundu K, Sarkar S, Paul BK, Das S. A Fast and Additive Free C-C Homo/Cross-Coupling Reaction in Reverse Micelle: An Understanding of Role of Surfactant, Water Content and Base on the Product Yield and Reaction Site. ChemistrySelect 2017. [DOI: 10.1002/slct.201601986] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- Barnali Kar
- Department of Chemistry; University of North Bengal; Darjeeling 734 013 India
| | - Soumik Bardhan
- Department of Chemistry; University of North Bengal; Darjeeling 734 013 India
| | - Prasanjit Ghosh
- Department of Chemistry; University of North Bengal; Darjeeling 734 013 India
| | - Bhaskar Ganguly
- Department of Chemistry; University of North Bengal; Darjeeling 734 013 India
| | - Kaushik Kundu
- Surface and Colloid Science Laboratory, Geological Studies Unit; Indian Statistical Institute; Kolkata 700 108 India
- Department Inorganic and Physical Chemistry; Indian Institute of Science; Bangalore- 560012 India
| | - Sonali Sarkar
- Department of Chemistry; University of North Bengal; Darjeeling 734 013 India
| | - Bidyut Kumar Paul
- Surface and Colloid Science Laboratory, Geological Studies Unit; Indian Statistical Institute; Kolkata 700 108 India
| | - Sajal Das
- Department of Chemistry; University of North Bengal; Darjeeling 734 013 India
| |
Collapse
|
3
|
Severinsen R, Bourne GT, Tran TT, Ankersen M, Begtrup M, Smythe ML. Library of Biphenyl Privileged Substructures using a Safety-Catch Linker Approach. ACTA ACUST UNITED AC 2008; 10:557-66. [DOI: 10.1021/cc800006g] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Rune Severinsen
- Institute for Molecular Bioscience, The University of Queensland, St. Lucia, 4072 Queensland, Australia, Purification & Chemistry, Novo Nordisk A/S, Novo Nordisk Park, 2760, Maaløv, Denmark, Protagonist Pty. Ltd., Level 7 Queensland Bioscience Precinct, 306 Carmody Road, St Lucia, 4072 Australia, and The Danish University for Pharmaceutical Sciences, Universitetsparken 2, 2100 Copenhagen, Denmark
| | - Gregory T. Bourne
- Institute for Molecular Bioscience, The University of Queensland, St. Lucia, 4072 Queensland, Australia, Purification & Chemistry, Novo Nordisk A/S, Novo Nordisk Park, 2760, Maaløv, Denmark, Protagonist Pty. Ltd., Level 7 Queensland Bioscience Precinct, 306 Carmody Road, St Lucia, 4072 Australia, and The Danish University for Pharmaceutical Sciences, Universitetsparken 2, 2100 Copenhagen, Denmark
| | - Tran T. Tran
- Institute for Molecular Bioscience, The University of Queensland, St. Lucia, 4072 Queensland, Australia, Purification & Chemistry, Novo Nordisk A/S, Novo Nordisk Park, 2760, Maaløv, Denmark, Protagonist Pty. Ltd., Level 7 Queensland Bioscience Precinct, 306 Carmody Road, St Lucia, 4072 Australia, and The Danish University for Pharmaceutical Sciences, Universitetsparken 2, 2100 Copenhagen, Denmark
| | - Michael Ankersen
- Institute for Molecular Bioscience, The University of Queensland, St. Lucia, 4072 Queensland, Australia, Purification & Chemistry, Novo Nordisk A/S, Novo Nordisk Park, 2760, Maaløv, Denmark, Protagonist Pty. Ltd., Level 7 Queensland Bioscience Precinct, 306 Carmody Road, St Lucia, 4072 Australia, and The Danish University for Pharmaceutical Sciences, Universitetsparken 2, 2100 Copenhagen, Denmark
| | - Mikael Begtrup
- Institute for Molecular Bioscience, The University of Queensland, St. Lucia, 4072 Queensland, Australia, Purification & Chemistry, Novo Nordisk A/S, Novo Nordisk Park, 2760, Maaløv, Denmark, Protagonist Pty. Ltd., Level 7 Queensland Bioscience Precinct, 306 Carmody Road, St Lucia, 4072 Australia, and The Danish University for Pharmaceutical Sciences, Universitetsparken 2, 2100 Copenhagen, Denmark
| | - Mark L. Smythe
- Institute for Molecular Bioscience, The University of Queensland, St. Lucia, 4072 Queensland, Australia, Purification & Chemistry, Novo Nordisk A/S, Novo Nordisk Park, 2760, Maaløv, Denmark, Protagonist Pty. Ltd., Level 7 Queensland Bioscience Precinct, 306 Carmody Road, St Lucia, 4072 Australia, and The Danish University for Pharmaceutical Sciences, Universitetsparken 2, 2100 Copenhagen, Denmark
| |
Collapse
|
4
|
Abdel-Magid AF, Mehrman SJ. A Review on the Use of Sodium Triacetoxyborohydride in the Reductive Amination of Ketones and Aldehydes. Org Process Res Dev 2006. [DOI: 10.1021/op0601013] [Citation(s) in RCA: 336] [Impact Index Per Article: 18.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Ahmed F. Abdel-Magid
- Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Department of Chemical Development, Spring House, Pennsylvania 19477, U.S.A
| | - Steven J. Mehrman
- Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Department of Chemical Development, Spring House, Pennsylvania 19477, U.S.A
| |
Collapse
|
6
|
Wang GT, Wang X, Wang W, Hasvold LA, Sullivan G, Hutchins CW, O'Conner S, Gentiles R, Sowin T, Cohen J, Gu WZ, Zhang H, Rosenberg SH, Sham HL. Design and synthesis of o-trifluoromethylbiphenyl substituted 2-amino-nicotinonitriles as inhibitors of farnesyltransferase. Bioorg Med Chem Lett 2005; 15:153-8. [PMID: 15582430 DOI: 10.1016/j.bmcl.2004.10.014] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2004] [Revised: 10/05/2004] [Accepted: 10/06/2004] [Indexed: 11/19/2022]
Abstract
A non-methionine FT inhibitor lead structure (1) was designed through computer modeling of the peptidomimetic FT inhibitor ABT839. Optimization of this lead resulted in compounds 2e and 2g, with FT IC(50) values of 1.3 and 1.8 nM, GGT IC(50) of 1400 nM, and EC(50) (Ras processing) values of 13 and 11 nM, respectively.
Collapse
Affiliation(s)
- Gary T Wang
- Global Pharmaceutical Research & Development, Abbott Laboratories, Abbott Park, IL 60064, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Millet R, Domarkas J, Houssin R, Gilleron P, Goossens JF, Chavatte P, Logé C, Pommery N, Pommery J, Hénichart JP. Potent and Selective Farnesyl Transferase Inhibitors. J Med Chem 2004; 47:6812-20. [PMID: 15615530 DOI: 10.1021/jm030502y] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
We recently described a novel series of CA(1)A(2)X peptidomimetics as farnesyl transferase inhibitors (FTIs). These compounds possess an N-(4-piperidinyl)benzamide scaffold mimicking A(1)A(2) residue. Extensive exploration of structure--activity relationships revealed that replacement of cysteine by substituted benzylimidazoles provided nanomolar FTIs with in vitro activities (18e, IC(50) = 4.60 nM on isolated enzyme, EC(50) = 20.0 nM for growth inhibition on a tumor cell line). The molecular docking of 18e and 19e in the active site of the enzyme provided details of key interactions with the protein and showed that the methionine or phenylalanine residue fits into the aryl binding site.
Collapse
Affiliation(s)
- Régis Millet
- Institut de Chimie Pharmaceutique Albert Lespagnol, EA 2692, Université de Lille 2, BP 83 rue du Professeur Laguesse, 59006 Lille, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Polley MJ, Winkler DA, Burden FR. Broad-Based Quantitative Structure−Activity Relationship Modeling of Potency and Selectivity of Farnesyltransferase Inhibitors Using a Bayesian Regularized Neural Network. J Med Chem 2004; 47:6230-8. [PMID: 15566293 DOI: 10.1021/jm049621j] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Inhibitors of the enzyme farnesyltransferase show potential as novel anticancer agents. There are many known inhibitors, but efforts to build predictive SAR models have been hampered by the structural diversity and flexibility of inhibitors. We have undertaken for the first time a QSAR study of the potency and selectivity of a large, diverse data set of farnesyltransferase inhibitors. We used novel molecular descriptors based on binned atomic properties and invariants of molecular matrices and a robust, nonlinear QSAR mapping paradigm, the Bayesian regularized neural network. We have built robust QSAR models of farnesyltransferase inhibition, geranylgeranyltransferase inhibition, and in vivo data. We have derived a novel selectivity index that allows us to model potency and selectivity simultaneously and have built robust QSAR models using this index that have the potential to discover new potent and selective inhibitors.
Collapse
Affiliation(s)
- Mitchell J Polley
- Centre for Complexity in Drug Design, CSIRO Molecular Science, Private Bag 10, Clayton South MDC, Clayton 3169, Australia
| | | | | |
Collapse
|
9
|
Wang L, Wang GT, Wang X, Tong Y, Sullivan G, Park D, Leonard NM, Li Q, Cohen J, Gu WZ, Zhang H, Bauch JL, Jakob CG, Hutchins CW, Stoll VS, Marsh K, Rosenberg SH, Sham HL, Lin NH. Design, Synthesis, and Biological Activity of 4-[(4-Cyano-2-arylbenzyloxy)-(3-methyl-3H-imidazol-4-yl)methyl]benzonitriles as Potent and Selective Farnesyltransferase Inhibitors. J Med Chem 2004; 47:612-26. [PMID: 14736242 DOI: 10.1021/jm030434f] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
A novel series of 4-[(4-cyano-2-arylbenzyloxy)-(3-methyl-3H-imidazol-4-yl)methyl]benzonitriles have been synthesized as selective farnesyltransferase inhibitors using structure-based design. X-ray cocrystal structures of compound 20-FTase-HFP and A313326-FTase-HFP confirmed our initial design. The decreased interaction between the aryl groups and Ser 48 in GGTase-I binding site could be one possible reason to explain the improved selectivity for this new series of FTase inhibitors. Medicinal chemistry efforts led to the discovery of compound 64 with potent cellular activity (EC(50) = 3.5 nM) and outstanding pharmacokinetic profiles in dog (96% bioavailable, 18.4 h oral t(1/2), and 0.19 L/(h x kg) plasma clearance).
Collapse
Affiliation(s)
- Le Wang
- Globe Pharmaceutical R and Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6101, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Abstract
Lead compounds with the potential to progress to viable drug candidates have been identified from libraries using several strategies. These include rapid screening of large diverse collections, thematic libraries, project-directed libraries, and three-dimensional molecular models of corporate databases. There have been numerous success stories, including the identification of several clinical candidates.
Collapse
Affiliation(s)
- A Golebiowski
- Procter & Gamble Pharmaceuticals, Health Care Research Center 45040-8006, Mason, OH, USA.
| | | | | |
Collapse
|
14
|
Derdau V, Snieckus V. Condensation of laterally lithiated o-methyl and o-ethyl benzamides with imines mediated by (-)-sparteine. Enantioselective synthesis of tetrahydroisoquinolin-1-ones. J Org Chem 2001; 66:1992-8. [PMID: 11300891 DOI: 10.1021/jo001369+] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
The first asymmetric synthesis of tetrahydroisoquinolin-1-ones using a (-)-sparteine-mediated lateral metalation-imine addition sequence to furnish 3-phenyl tetrahydroisoquinolinones 3a with enantioselectivities up to 81% ee is described (Scheme 4). For amide 7b, imine addition products 10 and 11 have been obtained with high diastereoselectivities (91-97% de) and enantioselectivities (91-98% ee) (Scheme 8).
Collapse
Affiliation(s)
- V Derdau
- Department of Chemistry, Queen's University, Kingston, ON K7L 3N6, Canada
| | | |
Collapse
|